Guidance outlines regulatory frameworks for phage therapeutic products, implying enhanced safety protocols.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Coxon et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: